中山大学中山医学院药理教研室二级教授，博士生导师，广东省脑功能与脑疾病重点实验室主任，中山医学院蛋白质组学研究中心主任，广东省普通高校蛋白质组学转化医学重点实验室主任。
长期从事药理学与分子神经生物学研究，主要研究领域是神经元凋亡及其信号转导，帕金森病机制与治疗新靶标，蛋白质组学。其研究成果对于揭示神经退行性疾病发生的本质并寻找、确立药物靶点，从而进一步达到有效防治神经退行性疾病的目的具有重要意义。
获得了包括国家自然科学基金重点项目、“重大新药创制”科技重大专项、“973”计划、国家自然科学基金B类杰青、国家自然科学基金-广东省政府联合资助基金、广东省科技厅重点领域研发计划、广东省自然团队项目等二十多项基金资助，其中包括2018年度获得的两项重大项目：国家自然科学基金-广东联合基金集成项目(U1801681,1180万)及广东省科技厅重点领域研发计划“脑科学与类脑研究”专项项目(2018B030337001，4480万)。
组建了广东省第一家蛋白质组学研究中心并长期开展转化医学研究，逾180项临床课题获益；依托此平台，黎教授申请并获得2011年度“广东省普通高校蛋白质组学转化医学重点实验室”，从而填补了中山大学药理学国家重点学科一直没有重点实验室的空白。蛋白质组学研究中心位于何母太楼10楼，详情请见http://proteomics.sysu.edu.cn/。
近年来发表了40余篇SCI论文，其中作为第一作者或通讯作者在J Neurosci，Mol Cell Biol，J Biol Chem, Cell Death Differ, Proteomics和 Neuropharmacology等国际核心杂志发表了30余篇文章，并在Drug News Perspect上发表了相关专题综述。
作为第一完成人获得了2011年度高等学校科学研究优秀成果奖(教育部)一等奖和2011年度广东省科学技术奖励一等奖。
Professor Level II in the Department of Pharmacology at Zhongshan University School of Medicine, Doctoral Supervisor, Director of the Guangdong Key Laboratory of Brain Function and Brain Diseases, Director of the Proteomics Research Center at Zhongshan University School of Medicine, and Director of the Guangdong Provincial Key Laboratory of Proteomics in Translational Medicine.
Long-term research in pharmacology and molecular neurobiology, focusing on neuronal apoptosis and its signal transduction, mechanisms and new therapeutic targets for Parkinson's disease, and proteomics. His research is significant for revealing the essence of neurodegenerative diseases and identifying drug targets, thereby effectively preventing and treating these diseases.
Has received over twenty grants including key projects from the National Natural Science Foundation, the Major Scientific and Technological Special Project for "Significant New Drugs Development," the "973" Program, the National Science Fund for Distinguished Young Scholars (Category B), the Joint Fund of the National Natural Science Foundation of China and the Guangdong Provincial Government, the Key Areas Research and Development Program of the Guangdong Provincial Department of Science and Technology, and the Guangdong Natural Science Foundation Team Project. Notably, in 2018, secured two major projects: the National Natural Science Foundation-Guangdong Joint Fund Integration Project (U1801681, 11.8 million RMB) and the Guangdong Provincial Key Areas Research and Development Program "Brain Science and Brain-Like Research" Special Project (2018B030337001, 44.8 million RMB).
Established the first proteomics research center in Guangdong Province, which has long been engaged in translational medical research, benefiting over 180 clinical projects. Leveraging this platform, Professor Li applied for and obtained the "Guangdong Provincial Key Laboratory of Proteomics in Translational Medicine" in 2011, filling the gap of lacking a key laboratory in the national key discipline of pharmacology at Zhongshan University. The Proteomics Research Center is located on the 10th floor of the Hemutai Building. For more details, visit http://proteomics.sysu.edu.cn/.
In recent years, has published over 40 SCI papers, including 30 as the first or corresponding author in international core journals such as J Neurosci, Mol Cell Biol, J Biol Chem, Cell Death Differ, Proteomics, and Neuropharmacology, and has published related review articles in Drug News Perspect.
As the primary contributor, won the First Prize of the Higher Education Outstanding Scientific Research Output Award (Ministry of Education) in 2011 and the First Prize of the Guangdong Provincial Science and Technology Award in 2011.
